You're listening to this week in cardiology from the heart.org on medscape.

You can now access the latest in medical news on your Amazon Alexa enabled device.

Join me, Perry Wilson, every weekday morning for Medscape Medical Minute,

where I highlight the top medical stories of the day.

To add Medscape Medical Minute to your flash briefing, search for Medscape Medical

Minute on Amazon and click enable. Or open the Amazon Alexa app, go to Skills, search for Medscape

Medical Minute and click enable. Then say,

Alexa, what's the news or Alexa, what's my flash briefing? I hope you'll join us.

Hi everyone, this is John Mandrola from the Heart.org Medscape Cardiology and this is this week in

cardiology for January 17th, 2020. This week another note on Excel. Amyloid cardiomyopathy, drug prices, palliative care

and cardiology and gender bias at medical meetings. This week I am keeping it brief on Excel, a controversial trial of Left Main PCI versus

Cavage.

The most recent news is the Society of Thoracic Surgeons, S. T.S.

drafted a letter saying that since any final conclusions

from Excel will not only affect the actions

of doctors and surgeons and regulatory agencies and third party payers but more importantly

these results will seriously impact the health and well-being of our patients and their families for

years to come. The society believes that, quote, the final interpretation

regarding the outcomes of the Excel study should wait until an independent analysis of all aspects of the study have been performed.

STS believes that such an analysis will provide our best opportunity to get it right

for the benefit of our patients now and in the future.

So all three major cardiothorask surgery societies, the EACTS, the Americanist Society the AATS, and STS have called for a reanalysis of Excel.

...